We are conducting a systemic reveiw about secondary mutations and mechanisms of resistence in patients with EGFR+ non-small cell lung cancer who recieved TKIs therapy.

We work remotely using Trello as a platform for the team progress and google documents for sharing documents.

Participants need to have an access to Endnote so we can share files.

If you interested in joining, message me. We are looking for 2 or 3 interested participants.

Thanks

More Abdurahman Alloghbi's questions See All
Similar questions and discussions